Elsebet Oestergaard Nielsen

Title: Innovations by Elsebet Oestergaard Nielsen – A Trailblazer in Neuropharmacology

Introduction

Elsebet Oestergaard Nielsen is an innovative inventor based in Koebenhavn K, Denmark, known for her significant contributions to neuropharmacology. With two patents to her name, she has made noteworthy advancements in the field, creating compounds that hold promise for various neurological conditions.

Latest Patents

One of her latest patents is focused on "Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors." This invention pertains to novel alkyl substituted homopiperazine derivatives that are beneficial as monoamine neurotransmitter re-uptake inhibitors. It also highlights their application in therapeutic methods and pharmaceutical compositions that include these compounds.

Another recent patent is on "Diazabicyclic biaryl derivatives," which describes novel diazabicyclic biaryl derivatives identified as cholinergic ligands at the nicotinic acetylcholine receptors. These derivatives serve as modulators of monoamine receptors and transporters. Due to their pharmacological profiles, these compounds are potentially valuable in treating a variety of disorders ranging from neurodegeneration to inflammation and pain management.

Career Highlights

Elsebet Oestergaard Nielsen is a prominent figure at Neurosearch A/S, where she has applied her expertise in drug discovery and development. Her work aligns with the company's mission to pioneer innovative therapeutic solutions for mental health disorders and neurodegenerative diseases.

Collaborations

Throughout her career, Elsebet has collaborated with notable colleagues, including Dan Peters and Gunnar M. Olsen. These partnerships have been instrumental in driving forward the research and development of her groundbreaking inventions, shedding light on the complexities of neurotransmitter systems and their implications for therapeutic interventions.

Conclusion

Elsebet Oestergaard Nielsen's innovative work not only showcases her brilliance as an inventor but also has the potential to make a substantial impact in the field of neuropharmacology. With her patented inventions focusing on critical therapeutic areas, she stands as a key contributor to the ongoing advancement of medical science and the treatment of neurological disorders.